Can tracking a rare eye cancer pave the way for new treatments?

NCT ID NCT04588662

Ongoing Knowledge-focused Sponsor: Columbia University Source: ClinicalTrials.gov ↗

First seen Aug 11, 2026 · Last updated Aug 12, 2026 · Updated 1 time

Summary

This study follows people diagnosed with uveal melanoma, a rare eye cancer, over time to document the disease's natural course. Researchers will collect data on how the cancer progresses, including survival rates and whether it spreads. The goal is to build a detailed registry that can inform and support the development of new therapies for this condition.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to: If successful, this registry could provide crucial data to guide the development of new treatments for uveal melanoma, a rare eye cancer.
What could go wrong: This is an observational study, not a treatment trial, so it won't directly test any new therapy. Its value depends on long-term patient participation and data completeness.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for UVEAL MELANOMA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

uveal melanoma

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

UVEAL MELANOMA

Contacts and locations

Locations

Chatswood Eye Specialists

Chatswood, Australia
Clatterbridge Cancer Centre

Birkenhead, United Kingdom
Dr. Conway Private Rooms

Sydney, Australia
Erlangen

Erlangen, Germany
MD Anderson Cancer Center

Houston, Texas, 77030, United States
Massachusetts General Hospital

Boston, Massachusetts, 02114, United States
Memorial Sloan Kettering Cancer Center

New York, New York, 10065, United States
Mount Vernon Cancer Centre

Northwood, United Kingdom
Pennington Eye Clinic

North Adelaide, Australia
Perth Retina

Subiaco, Australia
Princess Margaret Cancer Center

Toronto, Canada
Royal Adelaide Hospital

Adelaide, Australia
Royal Victorian Eve and Ear Hospital

East Melbourne, Australia
Sheffield

Sheffield, United Kingdom
St. Vincent's Hospital

Sydney, Australia
Thomas Jefferson University Hospital

Philadelphia, Pennsylvania, 19107, United States
Western Eye Specialists

Maribyrnong, Australia

More trials for these conditions

Other studies related to the condition(s) this trial covers.